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suggesting that imaging at 4 hours p.i. is optimal to reach the highest 
contrast in [18F]HX4 PET images.  
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Purpose/Objective: To improve PET/CT image quality for small liver 
tumors by compensating breathing-induced motion. 
Materials and Methods: On our Philips Gemini PET/CT system, we 
acquired 4D CT and 4D PET scans for 6 patients by registering the 
breathing signal during the acquisition and binning the data into 10 
phase bins. The 4D CT dataset was used as an input for our home-
made implementation of a phase-based optical-flow method to 
determine the deformation vector field (DVF) between succeeding 
breathing phase bins. By subtracting the average of the 10 DVFs from 
each individual DVF, each phase could be mapped to the time-
weighted, averaged position.For each voxel in this averaged position, 
the median of the HU values of the 10 mapped phases was taken as a 
representative value for that voxel. This results in the 3D Mid Position 
(MidP) CT scan. In the same way all 10 phases of the 4DPET data were 
deformed based on the CT DVFs. In that case the average of the SUV 
for all 10 phases was taken, resulting in a MidP PET scan.  
Additionally, the PET scan was reconstructed in 3D in the conventional 
way, that is, without motion compensation. 
We overlaid the MidP PET and CT images to look for errors in the 
registration.  
For CT we determined the standard deviation in HU within a 
homogeneous part in the liver (Black circle) for the ten separate 
phases and the MidP scan and compared these. For PET we 
determined the standard deviation in SUV within the tumor region, 
indicated by the white circle, both for the conventional 3D PET scan 
and the MidP PET scan. Additionally, we determined the decrease in 
volume enclosed by 50% SUVmax comparing the conventional 3D with 
the MidP PET datasets. 
Results: The motion of the tumor due to breathing was on average 1.8 
(σ = 0.7)cm. The relative decrease in standard deviation in a 
homogeneous region in the original 4D CT data was about 67 (σ = 8)%. 
The standard deviation in the PET signal within the tumor showed an 
increase of about 5 (σ = 8)%. The PET values within the tumor region 
are in general not evenly distributed. In the conventional3D 
reconstruction this contrast is decreased due to motion blurring; for 
the motion compensated MidP PET dataset it is not. Therefore, the 
standard deviation in the MidP PET scan may be higher compared to 
the conventional 3Dscan. The volume decrease was on average 8% (σ = 
12%). It should be noted that for 4 of the lesions the decrease was 
almost zero, whereas for others the decrease was over 30%. 
Overall, more details could be seen on both CT and PET scan (see 
figure). 
Conclusions: Motion compensation in 4D PET/CT is feasible and 
increases image quality. The size of the lesions shown on the motion-
compensated PET images can decrease considerably compared to the 
conventional, non-compensated 3D PET scan.  
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Purpose/Objective: Dynamic contrast enhanced MRI (DCEMRI) of 
locally advanced cervical cancers and pharmacokinetic image analysis 
may be used to identify patients at risk of local relapse [1]. 
Furthermore, a pharmacokinetic image parameter, ABrix, has been 
shown to correlate with an hypoxic gene signature in such tumors [2]. 
Thus, DCEMRI may be used to identify patients with hypoxic disease 
and potentially to distinguish hypoxic from normoxic tissue. 
Therefore, it is of interest to explore strategies taking such biological 
image information into account to improve radiotherapy outcome. 
Materials and Methods: DCEMR images of 23 patients with locally 
advanced cervical cancers were used. The dynamic image series were 
analyzed in terms of the pharmacokinetic ‘Brix’ model voxel byvoxel 
in each patient. The resulting ABrix maps were imported into Oncentra 
Brachy (Nucletron, the Netherlands) and used to define an hypoxic, or 
biological, target volume (BTV). T2-weighted images were used to 
define the gross tumor volume (GTV). Using a ring applicator, 
including needles when necessary, two brachytherapy treatment 
planning approaches were investigated. In approach 1, a conventional, 
non-biological image guided approach was followed where GTV was 
given the highest dose possible without compromising the dose 
constraints for the organs at risk. In approach 2, BTV was boosted to 
the highest dose possible, still without compromising other dose 
objectives. The results were analyzed in terms of D90 (fraction dose to 
90% of volume) to the targets. 
Results: The patients presented highly different hypoxic BTVs, both in 
size and location within the GTV. The hypoxic fraction (BTV/GTV 
volume ratio) ranged from 0.06 to 0.86. For some patients, it was 
possible to escalate the dose to the BTV (approach 2) with up to 30 % 
compared to approach 1, while others could not be further escalated 
without violating the dose constrains to the OARs. For approach 1, D90 
to GTV was 9.7±2.0 Gy while D90 for BTV was 11.2±2.9 Gy (cohort-
based mean ± 1 s.d.). Following approach 2, these D90’s were 
10.1±2.3Gy and 12.2±3.4Gy, respectively.  
Conclusions: In conventional image guided brachytherapy, the 
hypoxic subvolume usually receives a higher dose than the rest of the 
GTV. Further dose escalation is possible for a selection of patients 
with small and/or centrally located hypoxic BTVs. 
[1] E. Andersen, K.H. Hole, K.V. Lund et al. Pharmacokinetic 
parameters derived from dynamic contrast enhanced MRI of cervical 
cancers predict chemoradiotherapy outcome. Radiother Oncol 
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[2] C. Halle, E. Andersen, M. Lando et al. Hypoxia-Induced Gene 
Expression in Chemoradioresistant Cervical Cancer Revealed by 
Dynamic Contrast-Enhanced MRI. Cancer Res 2012; 72: 5285-5295. 
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Purpose/Objective: Understanding the etiology of tumor response is 
the key to adaptive radiotherapy. Both Dynamic Contrast Enhanced 
(DCE)-MRI and Diffusion Weighted (DW)-MRI are techniques to gain 
information about the microenvironment of tumors. Combining these 
two techniques opens the possibility to investigate wherethey carry 
similar and complimentary information.  
Materials and Methods: A 3T MRI (Philips Achieva 3T-X) was used 
before start of EBRT in 8 patients with locally advanced cervical 
cancer. DCE-MRI: 20-24slices, 5mm slice thickness, TE/TR: 1.4ms/2.9 
ms, 10o Flip Angle(FA), 2.27mm isotropic in-plane resolution . The 
bolus injected was 0.1mmol/kg Dotarem at 4ml/s, followed by a 5 ml 
saline flush. 120 dynamic acquisitions, equidistantly spaced by 2.1 
sec, were acquired. DWI-MRI: b=[150, 600, 1.000]s/mm2 TR = 1613 ms, 
TE=75 ms, the number of averages 6, matrix size was 112x112, 
resolution 2.5x2.5x4 mm. T2w images were used for tumor 
delineation. A moving average with a kernel of 0.15cc was applied to 
the images before post processing. The extended Tofts and Brix 
models were performed on the DCE-MRI. ADC was calculated assuming 
a log-linear relation between signal intensity and b-values. The 
correlation between perfusion parameters (Ktrans,ve,vp,ABrix,RSI90) and 
ADC was based on all voxels (figure 1) and evaluated using the Pearson 
correlation coefficient (r). 
Results: 
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Significant and weak positive correlation was found between ADC and 
ve (median r=0.205, range [-0.01 0.39]) as well as ADC and RSI90 
(r=0.155 [0.02 0.25]) in 7 out of the 8 patients. ADC versus Ktrans, vp, 
and ABrix showed no systematic positive or negative correlation with 
median and range of the Pearson correlation being: -0.025[-0.18 
0.32], -0.06[-0.19 0.38] and0.015[-0.04 0.26], respectively.  
Conclusions: The positive correlation between ADC and ve can partly 
be explained by considering that extracellular diffusion is higher than 
intracellular diffusion. Since ve is a measure of the extracellular 
extravascular volume fraction a positive correlation with ADC was 
expected. In other words, the water molecules are able to traverse a 
greater distance resulting in a greater ADC value when the space not 
occupied by cells or vessels (ve) is high. However, in median, only 4% 
of the variation in ADC can be explained by ve. Similarly, RSI90 only 
explains in median 2.4% of the variation in ADC for this population. 
Inhomogeneities in the static B0-field may lead to distortions of the 
ADC maps. These B0-field correction was not taken into account in the 
analysis and may influence the correlation between ADC and 
perfusion-parameters. The time between the DW-MRI and the DCE-MRI 
is around 20 min and in this time the correlations may be deteriorated 
by motion and changes in the microenvironment of the tumor. To 
conclude, it may be said that DW-MRI and the DCE-MRI are mainly 
supplying complementary information about the tumor micro-
environment.  
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Purpose/Objective: There is a clinical need for a functional imaging 
technique sensitive to tumour characteristics that gives 
radiosensitivity information (hypoxia, proliferative ability and 
angiogenesis). We investigated the use of nanoparticles (NPs) as a 
contrast agent for tumour characteristics; NPs can be functionalised 
with antibodies that enable cellular uptake via specific cellular 
receptors, thus acting as biomarkers for tumour characteristics. We 
present a technique that enables simultaneous imaging of multiple 
biomarkers and could potentially be extended to imaging bulk 3D 
volumes. 
Materials and Methods: We have devised an x-ray fluorescence (XRF) 
technique capable of imaging NP concentration. The novel XRF 
imaging module consisted of a focussing polycapillary optic coupled to 
an energy resolving silicon drift detector. Proof of concept imaging to 
distinguish two component metals was undertaken; a phantom 
consisting of gold and tantalum wires was constructed and imaged. 
Demonstration of sensitivity to NP uptake in cells was performed; this 
involved NP cellular uptake experiments with colorectal cancer cells 
(HT29) and stromal cells (fibroblasts 3T3) using varying incubation 
concentrations of 1.9 nm gold NPs. The NP loaded cells were nested in 
collagen type 1 to construct 3D in vitro cancer models to demonstrate 
the sensitivity of the XRF technique to NP concentration and 
distribution. 
Results: The technique demonstrated ability to distinguish two metal 
types in imaging mode. XRF imaging was performed of several slices of 
the 3D cancer model (with a challenging GNP concentration ratio of 
5:1 between the tumour mass (0.7 million HT29) and surrounding) and 
all component details could be clearly seen, with a delineated tumour 
mass emitting at 5x more than the surrounding cellular stroma (Fig 1). 
The XRF signal was linear with NP concentration down to GNP 
concentrations of 1ppm. 
 
  
Figure 1 Gold XRF image of 3D artificial cancer mass with gold NP 
inclusions 
 
Conclusions: XRF imaging techniques can be used to image the 
distribution and concentration of NPs at concentrations typically 
found in NP loaded tumours. The technique can also be used to 
discriminate between NPs of different metals, suggesting potential for 
multiple biomarkers to be imaged simultaneously. Further work on 
functionalising NPs is required.  
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Purpose/Objective: QA for IMRT and VMAT has evolved substantially. 
In recent years, various commercial 2D and 3D ionization chamber or 
diode detector arrays have become commercially available, allowing 
for absolute dose verification with near real time results. This has led 
to a wide uptake to replace point dose and film dosimetry and to 
facilitate QA streamlining. However, arrays are limited by their spatial 
resolution which may affect the sensitivity of the gamma index 
analysis. The purpose of this study was to compare the sensitivity of 
the gamma index analysis (γ) in the Delta4®, ArcCHECK®, PTW 2D-
Array seven29™ and Octavius II™ phantom combination, Gafchromic® 
EBT2 and composite Varian Portal Dosimetry EPID measurements. 
Materials and Methods: To evaluate the γsensitivity of the different 
systems, errors were designed with deliberate changes of 1, 2, 5mm 
introduced into prostate and head & neck IMRT and RapidArc™plans 
throughout all control points in all fields for one 5mm MLC leaf. 
Collimator rotation errors of 1, 2, and 5° were introduced into a 
prostate & pelvic nodes RapidArc plan. The errors were designed to 
test each system. The expected gamma index pass rate was simulated 
by exporting the normal plan predicted dose and the calculated dose 
for each error plan. The predicted γ was calculated in Verisoft v5, 
OmniPro I’mRT v7, Delta4 software, SNC Patient v6, Portal Dosimetry 
v10, and averaged. Measurements were evaluated against the 
unperturbed dose distribution calculated using Varian Eclipse™ in the 
relevant phantom. In all cases, global γ was used with a 20% threshold 
relative to a point selected in a high dose and low gradient region. 
Various criteria for γ were analysed, including the commonly used 
3%/3mm criteria. The γ based on measurement was compared against 
the predicted to evaluate the sensitivity of each system. The 
concordance correlation coefficient, ρc, was used to assess statistical 
agreement. 
Results: There was good agreement between the predicted γ from 
each software (all ρc>0.93 relative to the average prediction). A 
